Valuation: Olympus Corporation

Market Cap 1,837B 11.22B 9.86B 9.17B 8.41B 15.8B 1,081B 16.05B 109B 42.52B 531B 42.13B 41.22B P/E 2027 *
19x
P/E 2028 * 15.8x
Enterprise Value 1,907B 11.65B 10.23B 9.52B 8.73B 16.41B 1,122B 16.66B 113B 44.15B 552B 43.74B 42.8B EV / Sales 2027 *
1.79x
EV / Sales 2028 * 1.7x
Free-Float
94.53%
Yield 2027 *
1.78%
Yield 2028 * 1.86%
1 day+0.38%
1 week-2.37%
Current month+1.80%
1 month+5.75%
3 months+13.15%
6 months-9.02%
Current year-12.85%
1 week 1,703
Extreme 1703
1,789
1 month 1,636
Extreme 1636
1,818
Current year 1,302.5
Extreme 1302.5
2,137
1 year 1,302.5
Extreme 1302.5
2,168
3 years 1,302.5
Extreme 1302.5
2,867
5 years 1,302.5
Extreme 1302.5
3,198
10 years 758.75
Extreme 758.75
3,198
Manager TitleAgeSince
Chief Executive Officer 63 2025-05-31
Director of Finance/CFO 59 2026-03-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 69 2023-03-31
Director/Board Member 41 2019-05-31
Director/Board Member 63 2019-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.38%-2.37%-3.24%-24.38% 11.22B
-0.71%+6.72%+18.80%-0.46% 211B
-0.52%-6.05%-6.80%-25.11% 135B
+1.65%-2.29%-31.94%+1.99% 119B
+1.54%+0.50%-58.31%-15.57% 65.77B
-1.42%-3.62%+3.29%-9.87% 47.58B
+3.03%-0.17%-26.91%-33.60% 44.44B
-0.84%+5.41%+15.30%+8.84% 39.14B
-2.02%+1.54%+23.68%+30.76% 36.79B
-1.41%+3.99%+77.58%+2.50% 29.37B
Average -0.03%+0.19%+1.14%-6.49% 73.93B
Weighted average by Cap. +0.00%+0.33%-2.59%-6.69%

Financials

2027 *2028 *
Net sales 1,067B 6.52B 5.72B 5.32B 4.88B 9.18B 628B 9.32B 63.2B 24.69B 309B 24.46B 23.93B 1,108B 6.77B 5.94B 5.53B 5.07B 9.53B 652B 9.68B 65.65B 25.65B 320B 25.41B 24.86B
Net income 98.73B 603M 530M 493M 452M 849M 58.08B 862M 5.85B 2.29B 28.55B 2.26B 2.22B 118B 719M 632M 587M 539M 1.01B 69.25B 1.03B 6.97B 2.72B 34.05B 2.7B 2.64B
Net Debt 70.42B 430M 378M 351M 322M 606M 41.43B 615M 4.17B 1.63B 20.37B 1.61B 1.58B 52.07B 318M 279M 260M 238M 448M 30.63B 455M 3.09B 1.21B 15.06B 1.19B 1.17B
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
28,138
Date Price Change Volume
26-07-24 ¥1,729.50 +0.38% 3,047,700
26-07-23 ¥1,723.00 -0.17% 4,138,900
26-07-22 ¥1,726.00 -1.65% 4,597,100
26-07-21 ¥1,755.00 -0.93% 4,092,100
26-07-17 ¥1,771.50 +1.40% 6,334,600
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,729.50JPY
Average target price
1,913.08JPY
Spread / Average Target
+10.61%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 7733 Stock